Jubilant Organosys has realigned the businesses of its two recently acquired companies—HollisterStier Laboratories (US) and Draxis Specialty Pharmaceuticals (Canada)—into specialty pharmaceuticals and sterile injectables and non-sterile products areas. The company has also appointed Draxis’s COO and president of specialty pharmaceutical division Jean Pierre Robert as the CEO for the new specialty pharmaceutical organisation. In his new role, he will be responsible for the radiopharmaceuticals business of Draxis as well as the allergy extracts business of HollisterStier Laboratories.
Recently, in a landmark judgment by the Supreme Court in the case of Bank of Baroda v. Kotak Mahindra Bank, the Apex Court has determined over the limitation period applicable for executing a forei More
Helplinelaw can set up your session with quality and experienced lawyers to discuss and resolve your legal matters. You can avail consultation in form of sending questions, phone call or webchat discussion More